Please login to the form below

Not currently logged in
Email:
Password:

drug abuse

This page shows the latest drug abuse news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Indivior’s drug to fight opioid addiction

FDA panel backs Indivior’s drug to fight opioid addiction

FDA panel backs Indivior’ s drug to fight opioid addiction. The former RB pharma unit hopes for sales in the $1bn region. ... Indivior is on course to bring a new drug to market to tackle painkiller addiction in the US, offsetting the risks to its

Latest news

  • FDA panel backs Pfizer and Teva abuse-resistant painkillers FDA panel backs Pfizer and Teva abuse-resistant painkillers

    However, it would not back a label claim that the product could prevent abuse of the drug via the oral route, but said it could discourage abuse by people seeking to ... Last month the same panel also rejected an abuse-deterrent claim for KemPharm's

  • FDA gives green light for opioid addiction implant FDA gives green light for opioid addiction implant

    He added: “ Opioid abuse and addiction have taken a devastating toll on American families. ... Nora Volkow, director of the National Institute on Drug Abuse, said: “ Scientific evidence suggests that maintenance treatment with these medications in

  • FDA panel backs Novo Nordisk's liraglutide for obesity FDA panel backs Novo Nordisk's liraglutide for obesity

    FDA panel backs Novo Nordisk's liraglutide for obesity. Committee says diabetes drug could be used to reduce weight. ... Orexigen said yesterday that Contrave will have the benefit of a large Takeda salesforce promoting the drug and no need for

  • Acura must provide FDA more info on pain drug Acura must provide FDA more info on pain drug

    Acura must provide FDA more info on pain drug. Regulator questions abuse-resistant ability of Aversion. ... The FDA has demanded that Acura Pharmaceuticals submit more evidence on the abuse-deterrent abilities of its investigational pain drug.

  • FDA approves pain drug that has reduced risk of abuse FDA approves pain drug that has reduced risk of abuse

    FDA approves pain drug that has reduced risk of abuse. Purdue’ s Targiniq ER developed to deter snorting and injection. ... The US FDA has approved a new opioid-based pain treatment that is intended to reduce the risk of abuse by people who use the

More from news
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2013 Pharma deals during January 2013

    9.5. Savant HWP / National Institute on Drug Abuse. Development grant. ... 18-MC (18-methoxycoronaridine) as a treatment for drug addiction, obesity and compulsive behaviour.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • How digital content is helping physicians curb the opioid abuse epidemic

    using their state’ s Prescription Drug Monitoring Program (PDMP) database before prescribing opioids to a patient. ... After all, having physicians more frequently access these state PMDPs at the point of prescription can go a long way to preventing

More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics